Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Southeastern Grocers awards 50 local nonprofits with more than $480,000 in grant funds
-
Shorla Oncology Announces U.S. Food and Drug Administration (FDA) Expanded Approval of JYLAMVO™ (methotrexate), an Oncology and Autoimmune Drug for Pediatric Indications
-
EoS Fitness Celebrates a Decade of Growth and Community Impact
-
Auto Insurance Repair Cycle Times Improve but Price Increases Take a Toll, J.D. Power Finds
-
bebe stores, inc. Sells its Interests in bebe and Brookstone Brands for $46.6 million in Cash and Declares Special Dividend of $2.00 per Share
-
Today’s Workers Are Less Confident Than Actual Retirees, MFS 2024 Global Retirement Survey Finds
-
Ana Perez Joins PlanSource as Chief Marketing Officer
-
Toobit Unveils Redesigned Homepage, Elevating the User Experience for Global Crypto Traders
-
Atha Energy Announces Appointment of New Board Member and Chief Financial Officer
-
INVESTIGATION NOTICE: Girard Sharp Law Firm Encourages Iris Energy Limited (NASDAQ:IREN) Investors to Contact the Firm
-
Creative Realities Inc. Shines as a Top Workplace, Empowering Employees in Greater Louisville
-
Breckenridge Distillery and Flaviar Partner to Release Dad’s Stash Whiskey in Support of No-Shave November, Raising Funds for Fight Colorectal Cancer (Fight CRC)
-
Sagimet Biosciences Announces Successful Completion of End-of-Phase 2 Interactions with FDA on the Development of Denifanstat for MASH; Phase 3 Program Initiation Expected by End of 2024
-
2ONE Labs Receives PMTA 'Acceptance' for 2ONE® Nicotine Pouch brand from FDA Center for Tobacco Products
-
Amplify ETFs Launches Targeted 12% Annual Option Premium Fixed Income ETF: Amplify Bloomberg U.S. Treasury Target High Income ETF (CBOE: TLTP)
-
Bitfarms Nominates Andrew J. Chang for Election to the Board of Directors
-
Perspective Therapeutics to Participate in Upcoming Investor Conferences in November
-
Axsome Therapeutics Presents Data from Multiple Programs Spanning Its Innovative Neuroscience Portfolio at Psych Congress 2024
-
Macerich Refinances Top-Performing Queens Center at Favorable Terms
-
Coteau Grove Project, LLC Adds Bryan Perrin as Keyboardist and Vocalist
-
CodeRoad Completes Carve-Out from Mojix to Become a Leading Independent Provider of Software Development & Technology Services
-
Fractyl Health to Report Third Quarter 2024 Financial Results and Provide Business Updates on November 12, 2024
-
Crane NXT Acquires Smart Packaging Assets of TruTag Technologies, Further Expanding Capabilities in Product Security and Authentication Technologies
-
GXO Named as Top Contract Logistics Provider in Newsweek’s 2025 Ranking of America’s Most Reliable Companies
-
Mavenir Welcomes O-RAN ALLIANCE Report for Spectrum Aggregation in Multi-Vendor Deployments
-
Climb Channel Solutions Launches North American Partnership with Cybersecurity Vendor Fortra
-
Decisive action needed to achieve net zero by 2050, as world is currently on path for 2.5 ˚C to 3 ˚C global warming, according to Wood Mackenzie
-
Rego Payment Architectures, Inc. Selects Bangor Savings Bank as Its Banking Services Provider for Its Family Digital Wallet Platform
-
PENSKE AUTOMOTIVE GROUP REPORTS QUARTERLY RESULTS
-
Arbor Day Foundation Pledges 10 Million Trees to Areas Impacted by Hurricanes Helene, Milton
-
Optimove Placed Furthest on Completeness of Vision Axis in the 2024 Gartner® Magic Quadrant™ for Multichannel Marketing Hubs
-
Vizion Interactive Launches New One-Time Audit Packages to Boost Online Visibility and Marketing Effectiveness
-
Janus International Group Reports Third Quarter 2024 Financial Results
-
First Foundation Inc. Reports Third Quarter 2024 Financial Results
-
AECOM announces planned dates for fourth quarter and full year fiscal 2024 earnings results and conference call
-
PJT Partners Inc. Reports Third Quarter and Nine Months 2024 Results
-
Chengdu's Wuhou district sets ambitious course for music industry
-
Kiora Pharmaceuticals Receives Investigational New Drug Approval to Initiate ABACUS-2, a Phase 2 Clinical Trial of KIO-301 for the Treatment of Retinitis Pigmentosa
-
Windstream Partners Selects HUB to Scale Performance Reporting and Streamline Operations
-
MSCI Reports Financial Results for Third Quarter and Nine Months 2024
-
Tenet Reports Strong Third Quarter 2024 Results; Raises 2024 Financial Outlook
-
Rithm Capital Corp. Announces Third Quarter 2024 Results
-
Westwater Resources Applauds Treasury Department Guidance on 45X Advanced Manufacturing Production Credit
-
Pfizer Reports Strong Third-Quarter 2024 Results And Raises 2024 Guidance
-
Rithm Capital Corp. Elects Ranjit Kripalani and William Addas to the Board of Directors
-
Spire Global and OroraTech Awarded NASA Contract for Wildfire Monitoring
-
EILEAN THERAPEUTICS ANNOUNCES UPCOMING PRESENTATION OF A FIRST-IN-CLASS MALT1 DEGRADER AT ASH ANNUAL MEETING
-
Claritas NucMed Receives Clearance from Brazilian Regulator ANVISA to Market Claritas iPET™ Software Enabling Reduced Scan Time and Reduced Isotope Dosage in PET-CT/MRI Scans
-
The 'Fermentation' Effect of Beer and ICT Innovation
-
PetroChina Posted Another Record Operating Results for First Nine Months in 2024
